Contract Biomanufacturing Services Global Market - Forecast to 2025

The contract biomanufacturing global market is expected to grow at double digit CAGR to reach $36.6 billion by 2025. Biomanufacturing is a widely used term to describe manufacture of biologic molecules for various stages of drug development right from pre-clinical stage to commercial supply. The biologic drug manufacturing is a complex process involving huge capital and sound technical expertise. Many large and small pharmaceutical companies are turning to outsourcing the drug manufacture process to reduce capital investments on capacities and focus more on their core competencies.